ACH’s SVP of Policy & Government Affairs Stephanie Krenrich was featured in this article today on the 340B Rebate Model from Bridget Early at Modern Healthcare: “Drugmakers are upping their demands for transparency in the 340B Drug Pricing Program by imposing new requirements that have sparked ire among safety-net providers,” reports Bridget Early. “Novo Nordisk […]
“340B provider advocates, attorneys and program consultants offered largely mixed reactions Tuesday to the Health Resources Services and Administration’s (HRSA) reconsideration of 340B rebates following a federal court ruling that blocked the Trump administration’s initial rebate model from taking effect last month,” writes Shannon Young at 340B Report. HRSA is soliciting comments from stakeholders on […]
The 340B Drug Pricing Program is a game changer for federally qualified health centers (FQHCs), which have limited flexible funding streams at their disposal and often use their 340B savings for services that are non-reimbursable. The financial impact of these savings cannot be overstated, as they allow FQHCs to stretch their already scarce federal resources […]
As Congress considers reforms to the 340B Drug Pricing Program, Advocates for Community Health (ACH) has taken an active role in shaping policy proposals that reflect the operational realities of community health centers and prioritize patient access. Through sustained engagement with lawmakers around its innovative 340C legislative framework, ACH has helped advance reform concepts that […]
Shannon Young at 340B Report writes: “340B program stakeholders offered varying reactions following a late-December federal court ruling that halted the controversial rebate pilot from taking effect as planned, with providers celebrating the judge’s temporary pause, while the federal government and some drugmakers pushed back against the order.” Advocates for Community Health (ACH) spokesperson Sandy […]
Shannon Young from The 340B Report detailed a new ACH 340B research brief that underscores the vital role the program plays in supporting rural healthcare infrastructure. Based on a survey of its large community health center members, ACH’s findings reveal that nearly a quarter of all 340B savings are reinvested directly into care for rural […]
Survey finds nearly one in four 340B dollars invested in rural care, helping keep health centers open and expand telehealth, mobile, and school-based services Washington, D.C. — A new research brief released today by Advocates for Community Health (ACH) finds that the majority of the nation’s largest community health centers rely on savings from the […]
A recent article in the 340B Report by William Newton highlights a major advocacy effort led by Advocates for Community Health (ACH) to protect the 340B Drug Pricing Program. More than 260 healthcare providers and advocacy groups signed a December 5th letter urging Congressional leaders to take legislative action to pause the implementation of the […]
Washington, D.C. – Today, Advocates for Community Health (ACH) sent a letter to Congressional leaders urging legislative action to pause the rollout of the 340B Rebate Model Pilot Program, which is set to take effect January 1, 2026. The letter was signed by ACH and 263 national, state, and local partner organizations. The 340B program […]
The 340B Drug Pricing Program has been making health policy headlines in Washington. Much of the interest centers on potential program impacts as Congress considers radical changes to the 340B Program, which is a financial health policy key that enables our nation’s community health centers to keep their doors open. With this renewed attention comes […]
